.. Marquage-À-l-'indium-111, 165 I-2-1-Définition des paramètres de marquage de RAFT-RGD-DOTA-111 165 I-2-3-Evaluation du métabolisme in vivo 169 I-2-4-Evaluation pharmacologique du peptide marqué, p.172

M. Abrams, M. Juweid, C. Tenkate, D. Schwartz, M. Hauser et al., Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats, J Nucl Med, issue.12, pp.312022-312030, 1990.

R. Ajjan and P. Grant, Role of clotting factors and fibrin structure in predisposition to atherothrombotic disease, Expert Review of Cardiovascular Therapy, vol.3, issue.6, 2005.
DOI : 10.1586/14779072.3.6.1047

R. Alberto, R. Schlibi, A. Egli, and A. Schubiger, Novel organometallic aqua complex of technetium for the labeling of biomolecules: synthesis of [ 99m Tc(OH 2 ) 3 (CO) 3 ] + from [ 99m TcO 4 ] in aqueous solution and its reaction with a bifunctional ligand, J. Am

R. Alberto, R. Schlibi, and A. Schubiger, Tc, Journal of the American Chemical Society, vol.121, issue.25, pp.6076-6083, 1999.
DOI : 10.1021/ja990765a

A. Amann, C. Decristoforo, I. Ott, M. Wenger, D. Bader et al., Surfactant protein B labelled with [99mTc(CO)3(H2O)3]+ retains biological activity in vitro, Nuclear Medicine and Biology, vol.28, issue.3, pp.243-50, 2001.
DOI : 10.1016/S0969-8051(01)00192-5

V. Ardisson, Evaluation de nouveaux radiopharmaceutiques. Synthèse, évaluation, et biodistribution de nouveaux radioligands peptidiques de VCAM-1 et ? v ? 3 . Thèse de doctorat Méthode de recherche sur l'environement et la santé de l, 2006.
URL : https://hal.archives-ouvertes.fr/tel-00119156

M. Arnaout, Crystal structure of the extracellular segment of integrin ? V ? 3, Science, vol.294, pp.339-345, 2001.

G. Bandoli, A. Dolmella, M. Porchea, F. Refosco, and F. Tisato, Structural overview of technetium compounds (1993???1999), Coordination Chemistry Reviews, vol.214, issue.1, pp.43-90, 2001.
DOI : 10.1016/S0010-8545(00)00384-2

S. Banerjee, K. Maresca, L. Francesconi, J. Valliant, J. Babich et al., New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design, Nuclear Medicine and Biology, vol.32, issue.1, pp.1-20, 2005.
DOI : 10.1016/j.nucmedbio.2004.09.001

A. Beer, R. Haubner, M. Goebel, S. Luderschmidt, M. E. Spilker et al., Biodistribution and pharmacokinetics of the ? v ? 3 selective tracer 18 F-galacto-RGD in cancer patients, J Nucl Med, vol.46, issue.8, pp.1333-1374, 2005.

M. Béhé, G. Kluge, W. Becker, M. Gotthardt, and T. Behr, Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys, J. Nucl. Med, vol.46, pp.1012-1017, 2005.

D. Behrendt and P. Ganz, Endothelial function, The American Journal of Cardiology, vol.90, issue.10, pp.40-48, 2002.
DOI : 10.1016/S0002-9149(02)02963-6

J. R. Bender, Detection of injury-induced vascular remodeling by targeting activated alphavbeta3 integrin in vivo, Circulation, vol.110, pp.84-90, 2004.

J. Berliner and J. Heinecke, The role of oxidised lipoproteins in atherogenesis

I. Bernard-pierrot, J. Delbe, V. Rouet, M. Vigny, M. Kerros et al., Dominant Negative Effectors of Heparin Affin Regulatory Peptide (HARP) Angiogenic and Transforming Activities, Journal of Biological Chemistry, vol.277, issue.35, pp.32071-32077, 2002.
DOI : 10.1074/jbc.M202747200

S. Blankenberg, S. Barbaux, and L. Tiret, Adhesion molecules and atherosclerosis, Atherosclerosis, vol.170, issue.2, pp.191-203, 2003.
DOI : 10.1016/S0021-9150(03)00097-2

C. Bleeker-rovers, S. Bredie, J. Van-der-meer, F. Corstens, and W. Oyen, F-18- fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis, Neth. J. Med, vol.61, pp.323-332, 2003.

P. Blower and S. Prakash, The chemistry of rhenium in nuclear medicine, Perspect, Bioinorg. Chem, vol.4, pp.91-143, 1999.

J. Blum, H. Handmaker, and N. A. Rinne, Technetium Labeled Small Peptide Radiopharmaceuticals in the Identification of Lung Cancer Curr, Pharm. Des, pp.1827-1836, 2002.

A. Bolton and W. Hunter, I-containing acylating agent. Application to the radioimmunoassay, Biochemical Journal, vol.133, issue.3, pp.529-538, 1973.
DOI : 10.1042/bj1330529

A. Bolton, [2] Comparative methods for the radiolabeling of peptides, Methods. Enzymol, vol.124, pp.18-29, 1986.
DOI : 10.1016/0076-6879(86)24004-5

D. Boturyn, J. Coll, E. Garanger, M. Favrot, and P. Dumy, Template Assembled Cyclopeptides as Multimeric System for Integrin Targeting and Endocytosis, Journal of the American Chemical Society, vol.126, issue.18
DOI : 10.1021/ja049926n

N. Bouck, . Stellmach-v, and . C. Hsu-s, How Tumors Become Angiogenic, Adv.Cancer Res, vol.69, pp.135-174, 1996.
DOI : 10.1016/S0065-230X(08)60862-3

W. Breeman, P. Van-hagen, D. Kwekkeboom, T. Visser, and E. Krenning, Somatostatin receptor scintigraphy using [ 111 In-DTPA 0 ]RC-160 in humans: a comparison with [ 111 In-DTPA 0 ]octreotide, European Journal of Nuclear Medicine and Molecular Imaging, vol.25, issue.2, pp.182-186, 1998.
DOI : 10.1007/s002590050213

M. Brinkley, A brief survey of methods for preparing protein conjugates with dyes, haptens and crosslinking reagents, Bioconjugate Chemistry, vol.3, issue.1, pp.2-13, 1992.
DOI : 10.1021/bc00013a001

P. Brooks, . A. Montgomery, . Mp, M. Rosenfeld, R. Reisefeld et al., Integrin ??v??3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels, Cell, vol.79, issue.7, pp.1157-1164, 1994.
DOI : 10.1016/0092-8674(94)90007-8

P. Burke and S. Denardo, Antiangiogenic agents and their promising potential in combined therapy, Critical Reviews in Oncology/Hematology, vol.39, issue.1-2, pp.155-171, 2001.
DOI : 10.1016/S1040-8428(01)00115-9

P. Carmeliet, Angiogenesis in health and disease, Nature Medicine, vol.9, issue.6, pp.653-660, 2003.
DOI : 10.1038/nm0603-653

W. Casscells, M. Naghavi, and J. Willerson, Vulnerable Atherosclerotic Plaque: A Multifocal Disease, Circulation, vol.107, issue.16, 2003.
DOI : 10.1161/01.CIR.0000069329.70061.68

V. Caveliers, A. Goodbody, L. Tran, S. Peers, J. Thornback et al., Evaluation of 99m Tc-RP128 as a potential inflammation imaging agent ; human dosimetry and first clinical results, J. Nucl. Med, vol.42, pp.154-61, 2001.

E. Cahbannes, . Bernardini-s, and B. H. Wallerand-h, L'angiogenèse dans les tumeurs vésicales : indicateur pronostique et cible thérapeutique, Progrès en Urologie, vol.11, pp.417-427, 2001.

M. Chapman, From pathophysiology to targeted therapy for atherothrombosis: A role for the combination of statin and aspirin in secondary prevention, Pharmacology & Therapeutics, vol.113, issue.1
DOI : 10.1016/j.pharmthera.2006.08.005

J. Chen, S. Strand, and H. Sjögren, Optimization of Radioiodination and Biotinylation of Monoclonal Antibody Chimeric BR96: An Indirect Labeling using N-Succinimidyl-3-(tri-n-butylstannyl)benzoate Conjugate, Cancer Biotherapy & Radiopharmaceuticals, vol.11, issue.3, pp.217-243, 1996.
DOI : 10.1089/cbr.1996.11.217

X. Chen, R. Park, A. Shahinian, J. Bading, and P. Conti, Pharmacokinetics and tumor retention of 125 I-labeled RGD peptide are improved by PEGylation, Nucl. Med, issue.1

X. ). Chen, R. Park, A. Shahinian, M. Tohme, V. Khankaldyyan et al., 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis, Nuclear Medicine and Biology, vol.31, issue.2, pp.179-189, 2004.
DOI : 10.1016/j.nucmedbio.2003.10.002

X. Chen, E. Sievers, Y. Hou, R. Park, M. Tohme et al., Integrin ????3-Targeted Imaging of Lung Cancer, Neoplasia, vol.7, issue.3, pp.271-279, 2005.
DOI : 10.1593/neo.04538

X. Chen, Multimodality imaging of tumor integrin ? v ? 3 expression. Mini-ReV

R. Choudhuri, H. Zhang, S. Donnini, M. Ziche, and R. Bicknell, An angiogenic role for the neurokines midkine and pleiotrophin in tumorigenesis, Cancer. Res, vol.157, issue.9, pp.1814-1823, 1997.

M. Ciavolella, R. Tavolaro, M. Taurino, D. Loreto, M. Greco et al., Immunoscintigraphy of atherosclerotic uncomplicated lesions in vivo with a monoclonal antibody against D-dimers of insoluble fibrin, Atherosclerosis, vol.143, issue.1, pp.171-176, 1999.
DOI : 10.1016/S0021-9150(98)00272-X

E. Clarke and A. Martell, Stabilities of the Fe(III), Ga(III) and In(III) chelates of N,N???,N???-triazacyclononanetriacetic acid, Stabilities of the Fe(III), pp.273-280, 1991.
DOI : 10.1016/S0020-1693(00)86821-8

E. Clarke and A. Martell, Stabilities of trivalent metal ion complexes of the tetraacetate derivatives of 12-, 13- and 14-membered tetraazamacrocycles, Inorganica Chimica Acta, vol.190, issue.1, pp.37-46, 1992.
DOI : 10.1016/S0020-1693(00)80229-7

H. H. Coenen, J. Mertens, and B. Mazière, Radioionidation reactions for pharmaceuticals, compendium for effective synthesis startegies, 2006.

M. Comet and M. Vidal, Radiopharmaceutiques, chimie des radiotraceurs et application biologiques, pp.144-147, 1998.

R. Corti, R. Hutter, J. Badimon, and V. Fuster, Evolving Concepts in the Triad of Atherosclerosis, Inflammation and Thrombosis, Journal of Thrombosis and Thrombolysis, vol.17, issue.1, pp.35-44, 2004.
DOI : 10.1023/B:THRO.0000036027.39353.70

C. Cotsyfakis, A. D. Varvarigou, M. Papadopoulos, S. Stathaki, C. I. Stassinopoulou et al., Indium-111-labelled cationic complexes of aminothiols: structure-activity correlation, European Journal of Nuclear Medicine, vol.20, issue.4, pp.302-307, 1993.
DOI : 10.1007/BF00169805

J. Courty, M. Dauchel, D. Caruelle, M. Perderiset, and D. Barritault, Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin, Biochemical and Biophysical Research Communications, vol.180, issue.1
DOI : 10.1016/S0006-291X(05)81267-7

J. Courty, Développement d'une nouvelle stratégie anti-cancéreuse basée sur l'utilisation d'inhibiteurs de l'activité de HARP (concept et pharmaco-distribution par imagerie nucléaire), 2006.

J. Ramos, P. Connelly, and D. Milstone, A major role for VCAM-1, but not ICAM-1, in early atherosclerosis, J. Clin. Invest, vol.107, pp.1255-62, 2001.

J. Davies, J. Rudd, and P. Weissberg, Molecular and metabolic imaging of atherosclerosis, J. Nucl. Med, vol.45, pp.1898-1907, 2004.

M. Dechantsreiter, E. Planker, B. Mathä, E. Lohof, G. Holzemann et al., Integrin Antagonists, Journal of Medicinal Chemistry, vol.42, issue.16, pp.3033-3073, 1999.
DOI : 10.1021/jm970832g

C. Decristoforo, S. Mather, W. Cholewimski, E. Donnemiller, G. Riccabone et al., 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives, European Journal of Nuclear Medicine, vol.27, issue.9, pp.1318-1343, 2000.
DOI : 10.1007/s002590000289

M. Dejong, W. Bakker, E. Krenning, W. P. Breeman, M. Van-der-pluijm et al., Yttrium- 90 and indium-111 labeling, receptor binding and biodistribution of

M. Dejong, R. Barone, E. Krenning, B. Bernard, M. Melis et al., Megalin Is Essential for Renal Proximal Tubule Reabsorption of 111In-DTPA-Octreotide, J Nucl Med, vol.46, pp.1696-1700, 2005.

J. Delbe, F. Vacherot, K. Laaroubi, D. Barritault, and J. Courty, Effect of herparin on bovine epithelial lens cell proliferation induced by heparin affin regulatory peptide, Journal of Cellular Physiology, vol.186, issue.1, pp.47-54, 1995.
DOI : 10.1002/jcp.1041640107

I. Dijkgraaf, J. Kruijtzer, S. Liu, A. Soede, W. J. Oyen et al., Improved targeting of the ??v??3 integrin by multimerisation of RGD peptides, European Journal of Nuclear Medicine and Molecular Imaging, vol.25, issue.Suppl 2, pp.267-73, 2007.
DOI : 10.1007/s00259-006-0180-9

L. Dobrucki and A. Sinusas, Cardiovascular molecular imaging, Seminars in Nuclear Medicine, vol.35, issue.1, pp.73-81, 2005.
DOI : 10.1053/j.semnuclmed.2004.09.006

A. Egli, R. Alberto, L. Tannahill, R. Schibli, U. Abram et al., Organometallic 99m Tc-aquaion labels peptide to an unprecedented high specific activity, J. Nucl. Med, vol.40, pp.1913-1920, 1999.

X. Feng, R. Pak, L. Kroger, J. Moran, D. Denardo et al., New Anti-Cu-TETA and Anti-Y-DOTA Monoclonal Antibodies for Potential Use in the Pre-Targeted Delivery of Radiopharmaceuticals to Tumor, Hybridoma, vol.17, issue.2, pp.125-132, 1998.
DOI : 10.1089/hyb.1998.17.125

J. Fichna and A. Janecka, Synthesis of Target-Specific Radiolabeled Peptides for Diagnostic Imaging, Bioconjugate Chemistry, vol.14, issue.1, pp.3-17, 2003.
DOI : 10.1021/bc025542f

J. Folkman, E. Merler, C. Abernathy, and G. Williams, ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS, Journal of Experimental Medicine, vol.133, issue.2, pp.275-288, 1971.
DOI : 10.1084/jem.133.2.275

J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nature Medicine, vol.326, issue.1
DOI : 10.1038/359845a0

S. Fournel and S. Muller, Synthetic Peptides in the Diagnosis of Systemic Autoimmune Diseases, Current Protein & Peptide Science, vol.4, issue.4, pp.261-74, 2003.
DOI : 10.2174/1389203033487126

A. Fritzberg, S. Kasina, D. Eshima, and D. Johnson, Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement, J. Nucl. Med, vol.27, pp.111-117, 1986.

V. Fuster, J. Fallon, and Y. Nemerson, Coronary thrombosis, The Lancet, vol.348, issue.1, pp.7-10, 1996.
DOI : 10.1016/S0140-6736(96)98003-4

E. Garanger, Conception, Synthèse et Caractérisation de Nouveaux Systèmes de Guidage et de Vectorisation pour la Cancérologie. Thèse présentée à l, 2005.

A. Giannis and F. Rübsam, Integrin Antagonists and Other Low Molecular Weight Compounds as Inhibitors of Angiogenesis: New Drugs in Cancer Therapy, Angewandte Chemie International Edition in English, vol.36, issue.6
DOI : 10.1002/anie.199705881

M. Glaser, D. Collingridge, E. Aboagye, L. Bouchier-hayes, O. Hutchinson et al., Iodine-124 labelled Annexin-V as a potential radiotracer to study apoptosis using positron emission tomography, Applied Radiation and Isotopes, vol.58, issue.1
DOI : 10.1016/S0969-8043(02)00239-7

M. Gotthardt, J. Van-eerd-vismale, W. Oyen, M. De-jong, H. Zhang et al., Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides, Journal of Nuclear Medicine, vol.48, issue.4, pp.596-601, 2007.
DOI : 10.2967/jnumed.106.036020

K. Gottschalk and H. Kessler, The structures of integrins and integrin-ligand complexes: Implications for drug design and signal transduction, Angew. Chem

U. Hafeli, J. Yu, F. Farudi, L. Yuhua, and G. Tapolsky, Radiolabeling of magnetic targeted carriers (MTC) with indium-111, Nuclear Medicine and Biology, vol.30, issue.7, pp.761-769, 2003.
DOI : 10.1016/S0969-8051(03)00077-5

Y. Hamma-kourbali, I. Bernard-pierrot, M. Heroult, S. Dalle, D. Caruelle et al., Inhibition of the mitogenic, angiogenic and tumorigenic activities of pleiotrophin by a synthetic peptide corresponding to its C-thrombospondin repeat-I domain, Journal of Cellular Physiology, vol.280, issue.1, pp.250-259, 2008.
DOI : 10.1002/jcp.21191
URL : https://hal.archives-ouvertes.fr/hal-00172751

B. Hampton, D. Marshak, and W. Burgess, Structural and functional characterization of full-length heparin-binding growth associated molecule., Molecular Biology of the Cell, vol.3, issue.1, pp.85-90, 1992.
DOI : 10.1091/mbc.3.1.85

D. Hanahan and J. Folkman, Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis, Cell, vol.86, issue.3, pp.353-364, 1996.
DOI : 10.1016/S0092-8674(00)80108-7

G. Hansson, Inflammation, Atherosclerosis, and Coronary Artery Disease, New England Journal of Medicine, vol.352, issue.16
DOI : 10.1056/NEJMra043430

R. Hardoff, P. Zanzonico, F. Braegelmann, E. Herrold, R. Lees et al., Localization of (99m)Tc-Labeled ApoB Synthetic Peptide in Arterial Lesions of an Experimental Model of Spontaneous Atherosclerosis, Am J Ther, issue.2, pp.88-99, 1995.

T. Harris, S. Kalogeropoulos, T. Nguyen, S. Liu, J. Bartis et al., Receptor Antagonists for Tumor Imaging and Radiotherapy, Cancer Biotherapy & Radiopharmaceuticals, vol.18, issue.4, pp.627-641, 2003.
DOI : 10.1089/108497803322287727

W. Harris, Y. Chen, and K. Wein, Equilibrium Constants for the Binding of Indium(III) to Human Serum Transferrin, Inorganic Chemistry, vol.33, issue.22, pp.4991-4998, 1994.
DOI : 10.1021/ic00100a024

W. R. Harris and L. Messori, A comparative study of aluminum(III), gallium(III), indium(III), and thallium(III) binding to human serum transferrin, Coordination Chemistry Reviews, vol.228, issue.2, pp.237-262, 2002.
DOI : 10.1016/S0010-8545(02)00037-1

R. Haubner, D. Finsinger, and H. Kessler, Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of the??v??3 Integrin for a New Cancer Therapy, Angewandte Chemie International Edition in English, vol.36, issue.1314, pp.1374-1389, 1997.
DOI : 10.1002/anie.199713741

R. Haubner, H. Wester, U. Reuning, R. Senekowitsch-schmidtke, B. Diefenbach et al., Radiolabeled ? v ? 3 integrin antagonists : a new class of tracers for tumor targeting, J. Nucl. Med, vol.40, pp.1061-1071, 1999.

R. Haubner, H. Wester, F. Burkhart, R. Senekowisch-schmidtke, W. Weber et al., Glycolated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics, J. Nucl, issue.1

H. Wester, W. Weber, C. Mang, S. Ziegler, S. Goodman et al., Noninvasive imaging of ? v ? 3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography, Cancer. Res, vol.61, pp.1781-1785, 2001.

R. Haubner, W. A. Weber, A. Beer, E. Vabuliene, D. Reim et al., noninvasive visualization of the activated ? v ? 3 Integrin in Cancer Patients by Positron Emission Tomography and, PLoS MEDICINE, issue.2, p.70, 2005.

E. Hayman, M. D. Pierschbacher, and E. Ruoslahti, Detachment of cells from culture substrate by soluble fibronectin peptides, The Journal of Cell Biology, vol.100, issue.6, pp.1948-1954, 1985.
DOI : 10.1083/jcb.100.6.1948

M. Heeg and S. Jurisson, The Role of Inorganic Chemistry in the Development of Radiometal Agents for Cancer Therapy, Accounts of Chemical Research, vol.32, issue.12, pp.1053-1060, 1999.
DOI : 10.1021/ar980002c

M. Heroult, I. Bernard-pierrot, J. Delbé, Y. Hamma-kourbali, P. Katsoris et al., Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis, Oncogene, vol.23, issue.9, pp.1745-53, 2004.
DOI : 10.1038/sj.onc.1206879

D. Hnatowich, A. Mardirossen, M. Ruscowski, M. Fargarasi, F. Virji et al., Directly and indirectly technetium-99m-labeled antibodies ? a comparison of in vitro and animal in vivo properties, Nucl. Med. Chem, vol.34, pp.109-128, 1993.

A. Hoepping, J. Babich, J. Zubieta, K. Johnson, S. Machill et al., Synthesis and biological evaluation of two novel DAT-binding technetium complexes containing a piperidine based analogue of cocaine, Bioorganic & Medicinal Chemistry Letters, vol.9, issue.22, pp.3211-3215, 1999.
DOI : 10.1016/S0960-894X(99)00562-4

R. Hoffman, T cells in the pathogenesis of systemic lupus erythematosus, Clinical Immunology, vol.113, issue.1, pp.4-13, 2004.
DOI : 10.1016/j.clim.2004.05.001

Y. Huo and K. Ley, Adhesion molecules and atherogenesis, Acta Physiologica Scandinavica, vol.101, issue.1, pp.35-43, 2001.
DOI : 10.1002/(SICI)1521-4141(199902)29:02<700::AID-IMMU700>3.0.CO;2-1

R. Hynes, Integrins, Cell, vol.110, issue.6, pp.673-687, 2002.
DOI : 10.1016/S0092-8674(02)00971-6

L. Iuliano, A. Signore, S. Vallabajosula, A. Colavita, C. Camastra et al., Preparation and biodistribution of 99mtechnetium labelled oxidized LDL in man, Atherosclerosis, vol.126, issue.1, pp.131-172, 1996.
DOI : 10.1016/0021-9150(96)05888-1

J. James and J. Harley, B-cell epitope spreading in autoimmunity, Immunological Reviews, vol.144, issue.1, pp.185-200, 1998.
DOI : 10.1006/jaut.1997.0128

M. Janssen, W. Oyen, I. Dijkgraaf, L. J. Massuger, C. Frielink et al., Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model, Cancer. Res, vol.62, pp.6146-51, 2002.

H. Jin and J. Varner, Integrins: roles in cancer development and as treatment targets, British Journal of Cancer, vol.90, issue.3
DOI : 10.1038/sj.bjc.6601576

T. Jones-wilson, R. Motekaitis, Y. Sun, C. Anderson, A. Martell et al., New hydroxybenzyl and hydroxypyridylmethyl substituted triazacyclononane ligands for use with gallium(III) and indium(III), Nuclear Medicine and Biology, vol.22, issue.7, pp.859-868, 1995.
DOI : 10.1016/0969-8051(95)00033-T

A. Kaliyaperumal, M. Michaels, and S. Datta, Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of auto-immune T and B cells, J. Immunol, vol.162, pp.5775-83, 1999.

H. Kang, M. Michaels, B. Berner, and S. Datta, Very Low-Dose Tolerance with Nucleosomal Peptides Controls Lupus and Induces Potent Regulatory T Cell Subsets, The Journal of Immunology, vol.174, issue.6, pp.3247-55, 2005.
DOI : 10.4049/jimmunol.174.6.3247

M. Kantlehner, D. Finsinger, and J. Meyer, Selective RGD-Mediated Adhesion of Osteoblasts at Surfaces of Implants, Angewandte Chemie International Edition, vol.38, issue.4, pp.560-562, 1999.
DOI : 10.1002/(SICI)1521-3773(19990215)38:4<560::AID-ANIE560>3.0.CO;2-F

S. Karonen, Developments in techniques for radioiodination of peptide hormones and other proteins, J. Clin. Lab. Invest. Suppl, vol.201, pp.135-143, 1990.

D. Keire and M. Kobayashi, NMR Studies of the Metal-Loading Kinetics and Acid???Base Chemistry of DOTA and Butylamide-DOTA, Bioconjugate Chemistry, vol.10, issue.3, pp.454-463, 1999.
DOI : 10.1021/bc980128u

D. Keire, Y. Jang, L. Li, S. Dasgupta, W. Goddard et al., Chelators for radioimmunotherapy: I. NMR and ab initio calculation studies on 1, DO4Pr)and 1, pp.10-10

K. Kelly, J. Allport, A. Tsourkas, V. Shinde-patil, L. Josephson et al., Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle, Circulation Research, vol.96, issue.3, pp.327-363, 2005.
DOI : 10.1161/01.RES.0000155722.17881.dd

B. Kietselaer, C. Reutelingsperger, G. Heidendal, M. Daemen, W. Mess et al., Noninvasive Detection of Plaque Instability with Use of Radiolabeled Annexin A5 in Patients with Carotid-Artery Atherosclerosis, New England Journal of Medicine, vol.350, issue.14, 2004.
DOI : 10.1056/NEJM200404013501425

T. Kokubo, H. Uchida, and E. Choi, Integrin ? v ? 3 as a target in the prevention of neointimal hyperplasia j. vascular. surgery, pp.33-38, 2007.

F. Kolodgie, A. Petrov, R. Virmani, N. Narula, J. Verjans et al., Targeting of Apoptotic Macrophages and Experimental Atheroma With Radiolabeled Annexin V: A Technique With Potential for Noninvasive Imaging of Vulnerable Plaque, Circulation, vol.108, issue.25, pp.3134-3143, 2003.
DOI : 10.1161/01.CIR.0000105761.00573.50

K. Kopka, H. Breyholz, S. Wagner, M. Law, B. Riemann et al., Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo, Nuclear Medicine and Biology, vol.31, issue.2, pp.257-67, 2004.
DOI : 10.1016/j.nucmedbio.2003.08.003

C. Kumar, Integrin &#945;v&#946;3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis, Current Drug Targets, vol.4, issue.2, pp.123-131, 2003.
DOI : 10.2174/1389450033346830

H. Kung, B. Liu, D. Mankoff, M. Kung, J. Billings et al., A new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT-TECH, J. Nucl. Med, vol.31, pp.1635-1675, 1990.

D. Kwekkeboom, W. Bakker, P. M. Kooj, J. Erion, A. Srinivasan et al., Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma, European Journal of Nuclear Medicine, vol.27, issue.9, pp.1312-1329, 2000.
DOI : 10.1007/s002590000296

K. Laaroubi, J. Delbe, F. Vacherot, P. Desgranges, M. Tardieu et al., Angiogenic Activity of Human Recombinant Heparin Affin Regulatory Peptide, Growth Factors, vol.118, issue.2, pp.89-98, 1994.
DOI : 10.3109/08977199009011010

E. Lau, F. Lightstone, and M. Colvin, Environmental Effects on the Structure of Metal Ion-DOTA Complexes: An ab Initio Study of Radiopharmaceutical Metals Inorganic Chemistry, pp.9225-9232, 2006.

J. Leal, R. Luengo-fernandez, A. Gray, S. Petersen, and M. Rayner, Economic burden of cardiovascular diseases in the enlarged European Union, European Heart Journal, vol.27, issue.13, pp.1610-1619, 2006.
DOI : 10.1093/eurheartj/ehi733

J. Leonard, D. Novotnik, and R. Nierinckx, Technetium-99m-d,1-HMPAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT-a comparison with iodine-123 HIPDM, J. Nucl. Med, vol.27, pp.1819-1842, 1986.

P. Libby and P. Theroux, Pathophysiology of Coronary Artery Disease, Circulation, vol.111, issue.25, pp.3481-88, 2005.
DOI : 10.1161/CIRCULATIONAHA.105.537878

J. Lister-james, L. Knight, A. Mauer, L. Bush, B. Moyer et al., Thrombus imaging with a technetium-99m-labeled

S. Liu, D. Edwards, and A. Harris, Tc-Labeling of Hydrazino Nicotinamide-Modified Biologically Active Molecules Using Imine-N-Containing Heterocycles as Coligands, Bioconjugate Chemistry, vol.9, issue.5, pp.583-95, 1998.
DOI : 10.1021/bc9800116

S. Liu and D. Edwards, In-Labeled DTPA???Peptide Conjugates, Bioconjugate Chemistry, vol.12, issue.4, pp.630-634, 2001.
DOI : 10.1021/bc010013h

S. Liu, Fundamentals of Receptor-Based Diagnostic Metalloradiopharmaceuticals, Top. Curr. Chem, vol.222, issue.1, pp.259-278, 2002.
DOI : 10.1007/3-540-46009-8_8

S. Liu, A. Harris, N. Williams, and D. Edwards, Receptor Antagonist Useful for Imaging Infection and Inflammation, Bioconjugate Chemistry, vol.13, issue.4, pp.881-887, 2002.
DOI : 10.1021/bc010120b

S. Liu, The role of coordination chemistry in the development of target-specific radiopharmaceuticals, Chemical Society Reviews, vol.33, issue.7, pp.445-461, 2004.
DOI : 10.1039/b309961j

S. Liu, S. Robinson, and D. Edwards, Radiolabeled integrin ? v ? 3 antagonists as radiopharmaceuticals for tumor radiotherapy, Top. Curr. Chem, vol.252, pp.117-153, 2005.

S. Liu, Targeted Radiotracers for Tumor Imaging, Molecular Pharmaceutics, vol.3, issue.5, pp.472-487, 2006.
DOI : 10.1021/mp060049x

R. Ma, M. Welch, J. Reibenspies, and A. Martell, Stability of metal ion complexes of 1,4,7-tris(2-mercaptoethyl)-1,4,7-triazacylclonane (TACN-TM) and molecular structure of In(C12H24N3S3), Inorganica Chimica Acta, vol.236, issue.1-2, pp.75-82, 1995.
DOI : 10.1016/0020-1693(95)04617-I

Z. Mallat and A. Tedgui, Apoptosis in the vasculature: mechanisms and functional importance, British Journal of Pharmacology, vol.95, issue.suppl I, pp.947-962, 2000.
DOI : 10.1038/sj.bjp.0703407

Z. Mallat and A. Tedgui, Current Perspective on the Role of Apoptosis in Atherothrombotic Disease, Circulation Research, vol.88, issue.10, pp.998-1003, 2001.
DOI : 10.1161/hh1001.090571

W. Mark and . Konijnenberg, Is the Renal Dosimetry for [90Y-DOTA0, Tyr3]Octreotide Accurate Enough to Predict Thresholds for Individual Patients?, Cancer. Biother. Radiopharm, vol.18, pp.619-625, 2003.

M. Melis, E. Krenning, B. Bernard, R. Barone, T. Visser et al., Localisation and mechanism of renal retention of radiolabelled somatostatin analogues, European Journal of Nuclear Medicine and Molecular Imaging, vol.44, issue.10, pp.1136-1143, 2005.
DOI : 10.1007/s00259-005-1793-0

J. Merenmies and H. Rauvala, Molecular cloning of the 18-kDa growth associated protein of developing brain, J. Biol. Chem, vol.265, pp.16721-16725, 1990.

J. Mitchel, D. Waters, T. Lai, M. White, T. Alberghini et al., Identification of Coronary Thrombus With a IIb/IIIa Platelet Inhibitor Radiopharmaceutical, Technetium-99m DMP-444 : A Canine Model, Circulation, vol.101, issue.14, pp.1643-1649, 2000.
DOI : 10.1161/01.CIR.101.14.1643

F. Mitjans, T. Meyer, C. Fittschen, S. Goodman, A. Jonczyk et al., In vivo therapy of malignant melanoma by means of antagonists of ??v integrins, International Journal of Cancer, vol.59, issue.5, pp.716-739, 2000.
DOI : 10.1002/1097-0215(20000901)87:5<716::AID-IJC14>3.0.CO;2-R

F. Monneaux, J. Briand, and S. Muller, B and T cell immune response to small nuclear ribonucleoprotein particles in lupus mice: autoreactive CD4+ T cells recognize a T cell epitope located within the RNP80 motif of the 70K protein, European Journal of Immunology, vol.30, issue.8, pp.2191-2200, 2000.
DOI : 10.1002/1521-4141(2000)30:8<2191::AID-IMMU2191>3.0.CO;2-R

F. Monneaux, H. Dumortier, G. Steiner, J. Briand, and S. Muller, Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Faslpr and (NZB x NZW)F1 lupus mice, International Immunology, vol.13, issue.9, pp.1155-63, 2001.
DOI : 10.1093/intimm/13.9.1155

F. Monneaux, Key Sequences Involved in the Spreading of the Systemic Autoimmune Response to Spliceosomal Proteins, Scandinavian Journal of Immunology, vol.162, issue.1-2, pp.45-54, 2001.
DOI : 10.1006/jaut.2000.0380

F. Monneaux and S. Muller, Epitope spreading in systemic lupus erythematosus: Identification of triggering peptide sequences, Arthritis & Rheumatism, vol.44, issue.6, pp.1430-1438, 2002.
DOI : 10.1002/art.10263

F. Monneaux, J. Lozano, M. Patarroyo, J. Briand, and S. Muller, T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MRL/lpr mice, European Journal of Immunology, vol.33, issue.2, pp.287-96, 2003.
DOI : 10.1002/immu.200310002

F. Monneaux, V. Parietti, J. Briand, and S. Muller, Intramolecular T cell spreading in unprimed MRL/lpr mice: Importance of the U1-70k protein sequence 131-151, Arthritis & Rheumatism, vol.14, issue.10, pp.131-151
DOI : 10.1002/art.20510

F. Monneaux, J. Hoebeke, C. Sordet, C. Nonn, J. Briand et al., Selective Modulation of CD4+ T Cells from Lupus Patients by a Promiscuous, Protective Peptide Analog, The Journal of Immunology, vol.175, issue.9, pp.5839-5886, 2005.
DOI : 10.4049/jimmunol.175.9.5839

D. Onthank, S. Liu, P. Silva, J. Barrett, T. Harris et al., Receptor Antagonist:?? Different but Biologically Equivalent, Bioconjugate Chemistry, vol.15, issue.2, pp.235-241, 2004.
DOI : 10.1021/bc034108q

A. Otte, E. Jermann, M. Behe, M. Goetze, H. Bucher et al., DOTATOC: a powerful new tool for receptor mediated radionuclide therapy, Eur. J. Nucl. Med, vol.24, pp.792-795, 1997.

J. Pak, P. Benny, B. Spingler, K. Ortner, and R. Alberto, N Functionalization of Metal and Organic Protected L-Histidine for a Highly Efficient, Direct Labeling of Biomolecules with [Tc(OH2)3(CO)3]+, Chemistry - A European Journal, vol.9, issue.9, pp.2053-61, 2003.
DOI : 10.1002/chem.200204445

D. Pearson, J. Lister-james, W. Mcbride, D. Wilson, L. Martel et al., Somatostatin Receptor-Binding Peptides Labeled with Technetium-99m:?? Chemistry and Initial Biological Studies, Journal of Medicinal Chemistry, vol.39, issue.7, pp.1361-71, 1996.
DOI : 10.1021/jm950111m

S. Petersen, V. Peto, M. Rayner, J. Leal, R. Luengo-fernandez et al., European Cardiovascular Disease Statistics British Heart Foundation website

T. Poethko, G. Thumshirn, U. Hersel, F. Rau, R. Haubner et al., Improved tumor uptake, tumor retention and tumor/background ratios of pegylated RGD multimers, J. Nucl. Med, pp.44-46, 2003.

E. Prats, F. Aisa, M. Abos, L. Villavieja, F. Garcia-lopez et al., Mammography and 99m Tc-MIBI scintimammography in suspected breast cancer, J

M. Presta, P. Dell-'era, S. Mitola, E. Moroni, R. Ronca et al., Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis, Cytokine & Growth Factor Reviews, vol.16, issue.2, pp.159-178, 2005.
DOI : 10.1016/j.cytogfr.2005.01.004

A. Purohit, S. Liu, D. Casebier, and D. Edwards, Tc-Labeling of Small Biomolecules, Bioconjugate Chemistry, vol.14, issue.4, pp.720-727, 2003.
DOI : 10.1021/bc034059h

A. Purohit, S. Liu, C. Ellars, D. Casebier, S. Haber et al., Tc-Labeling of Small Biomolecules, Bioconjugate Chemistry, vol.15, issue.4, pp.728-737, 2004.
DOI : 10.1021/bc034141c

R. Qiao, W. Yan, H. Lum, and A. Malik, Arg-Gly-Asp peptide increases endothelial hydraulic conductivity: comparison with thrombin response, Am. J. Physiol, vol.269, pp.110-117, 1995.

M. Rajopadhye, A. Harris, H. Nguyen, K. Overoye, J. Bartis et al., RP593, a 99m Tclabeled ?v?3 antagonist, rapidly detects spontaneous tumors in mice and dogs, 47th Annual Meeting of SNM

S. Ram and D. Buchsbaum, A peptide-based bifunctional chelating agent for 99m Tc-and 186

H. Rauvala, An 18-kd heparin-binding protein of developing brain that is distinct from fibroblast growth factors, EMBO J, vol.8, p.2933, 1989.

D. Reichert, L. Jason, S. , A. Carolyn, and J. , Metal complexes as diagnostic tools coord, Chem. Rev, vol.184, pp.3-66, 1999.
DOI : 10.1016/s0010-8545(98)00207-0

J. Reubi, B. Waser, J. C. Schaer, U. Laederach, J. Erion et al., Unsulfated DTPA- and DOTA-CCK analogs as specific high-affinity ligands for CCK-B receptor-expressing human and rat tissues in vitro and in vivo, European Journal of Nuclear Medicine and Molecular Imaging, vol.25, issue.5, pp.481-490, 1998.
DOI : 10.1007/s002590050247

B. Rini and E. Small, Biology and Clinical Development of Vascular Endothelial Growth Factor???Targeted Therapy in Renal Cell Carcinoma, Journal of Clinical Oncology, vol.23, issue.5, pp.1028-1043, 2005.
DOI : 10.1200/JCO.2005.01.186

W. Risau, Mechanisms of angiogenesis, Nature, vol.386, pp.671-674, 1997.

J. Routsias, A. Tzioufas, and H. Moutsopoulos, The clinical value of intracellular autoantigens B-cell epitopes in systemic rheumatic diseases, Clinica Chimica Acta, vol.340, issue.1-2, pp.1-25, 2004.
DOI : 10.1016/j.cccn.2003.10.011

C. Ruegg and A. Mariotti, Vascular integrins: pleiotropic adhesion and signaling molecules in vascular homeostasis and angiogenesis, Cellular and Molecular Life Sciences, vol.60, issue.6, pp.1135-1157, 2003.
DOI : 10.1007/s00018-003-2297-3

M. Rusckowski, T. Qu, S. Gupta, A. Ley, and D. Hnatowich, A comparison in monkeys of 99m Tc labeled to a peptide by 4 methods, J. Nucl. Med, vol.42, pp.1870-1877, 2001.

J. Russell, J. O-'donoghue, R. Finn, J. Koziorowski, S. Ruan et al., Iodination of annexin V for imaging apoptosis, J. Nucl. Med, vol.43, pp.671-678, 2002.

M. Sadeghi, S. Krassilnikova, J. Zhang, A. Gharaei, H. Fassaei et al., Detection of Injury-Induced Vascular Remodeling by Targeting Activated ??v??3 Integrin In Vivo, Circulation, vol.110, issue.1, pp.84-90, 2004.
DOI : 10.1161/01.CIR.0000133319.84326.70

A. Safavy, D. Smith, A. Bazooband, and D. Buchsbaum, synthesis of a new diethylenetriaminepentaaceticacid (DTPA) bifunctional chelating agent, Bioconjug

P. Salven, A. Lymboussaki, P. Heikkila, H. Jaaskela-saari, B. Enholm et al., Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human Tumors, The American Journal of Pathology, vol.153, issue.1, pp.103-108, 1998.
DOI : 10.1016/S0002-9440(10)65550-2

L. Sancey, Evaluation d'un radioligand de l'intégrine ? v ? 3 , le Raft RGD, par l'imagerie moléculaire de l'angiogénèse tumorale, Thèse de doctorat Génie Biologique et Médical de l, 2006.

L. Sancey, V. Ardisson, L. Riou, M. Ahmadi, D. Marti-batlle et al., In vivo imaging of tumour angiogenesis in mice with the ??v??3 integrin-targeted tracer 99mTc-RAFT-RGD, European Journal of Nuclear Medicine and Molecular Imaging, vol.18, issue.Pt 19, pp.2037-2084, 2007.
DOI : 10.1007/s00259-007-0497-z
URL : https://hal.archives-ouvertes.fr/inserm-00176669

D. Satpati, K. Bapat, A. Mukherjee, . Banerjee-sh, K. Kothari et al., Preparation and bioevaluation of 99mTc-carbonyl complex of 5-hydroxy tryptamine derivative, Applied Radiation and Isotopes, vol.64, issue.8, pp.888-892, 2006.
DOI : 10.1016/j.apradiso.2006.03.003

M. Schafers, B. Riemann, K. Kopka, H. Breyholz, S. Wagner et al., Scintigraphic Imaging of Matrix Metalloproteinase Activity in the Arterial Wall In Vivo, Circulation, vol.109, issue.21, pp.2554-2563, 2004.
DOI : 10.1161/01.CIR.0000129088.49276.83

R. Schibli, K. Katti, C. Higginbotham, W. Volkert, and R. Alberto, In vitro and in vivo evaluation of bidentate, water-soluble phosphine ligands as anchor groups for the organometallic fac-[99mTc(CO)3]+-core, Nuclear Medicine and Biology, vol.26, issue.6, pp.711-716, 1999.
DOI : 10.1016/S0969-8051(99)00028-1

R. Schibli, R. Labella, R. Alberto, L. Garcia-garayoa, K. Ortner et al., Influence of the denticity of ligand systems on the in vitro and in vivo behavior of 99m Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules

R. Schibli, R. Schwartzbach, R. Alberto, K. Ortner, H. Schmalle et al., and Synthesis of Tailor-Made Bifunctional Ligand Systems, Bioconjugate Chemistry, vol.13, issue.4, pp.750-756, 2002.
DOI : 10.1021/bc015568r

D. Schwartz, M. Abrams, M. Hauser, F. Gaul, S. Larsen et al., Preparation of hydrazino-modified proteins and their use for the synthesis of technetium-99m-protein conjugates, Bioconjugate Chemistry, vol.2, issue.5, pp.333-339, 1991.
DOI : 10.1021/bc00011a007

K. Schwochau, Technetium Radiopharmaceuticals???Fundamentals, Synthesis, Structure, and Development, Angewandte Chemie International Edition in English, vol.33, issue.22, pp.2258-67, 1994.
DOI : 10.1002/anie.199422581

M. Shimaoka and T. Springer, Therapeutic antagonists and conformational regulation of integrin function, Nature Reviews Drug Discovery, vol.2, issue.9, pp.703-716, 2003.
DOI : 10.1038/nrd1174

A. Signore, A. Annovazzi, M. Chianelli, F. Corsetti, C. Van-de-wiele et al., Peptide radiopharmaceuticals for diagnosis and therapy, Eur J Nucl Med, issue.10, pp.281555-65, 2001.

G. Sivolapenko, D. Skarlos, D. Pectasides, E. Stathopoulou, A. Milonakis et al., Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide, European Journal of Nuclear Medicine and Molecular Imaging, vol.25, issue.10, pp.1383-1389, 1998.
DOI : 10.1007/s002590050312

P. Soulie, M. Heroult, I. Bernard, M. Kerros, P. Milhiet et al., IMMUNOASSAY FOR MEASURING THE HEPARIN-BINDING GROWTH FACTORS HARP AND MK IN BIOLOGICAL FLUIDS, Journal of Immunoassay and Immunochemistry, vol.119, issue.1, pp.33-48, 2002.
DOI : 10.1006/abio.1997.2494

A. Sposito and M. Chapman, Statin Therapy in Acute Coronary Syndromes: Mechanistic Insight Into Clinical Benefit, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.22, issue.10, pp.1524-1534, 2002.
DOI : 10.1161/01.ATV.0000032033.39301.6A

S. Steinhubl and D. Moliterno, The Role of the Platelet in the Pathogenesis of Atherothrombosis, American Journal of Cardiovascular Drugs, vol.2, issue.6, pp.399-408, 2005.
DOI : 10.2165/00129784-200505060-00007

J. Stimmel, F. Kull, and . Jr, Samarium-153 and Lutetium-177 Chelation Properties of Selected Macrocyclic and Acyclic Ligands, Nuclear Medicine and Biology, vol.25, issue.2, pp.117-125, 1998.
DOI : 10.1016/S0969-8051(97)00151-0

G. Stoica, A. Kuo, A. Aigner, I. Sunitha, B. Souttou et al., Identification of Anaplastic Lymphoma Kinase as a Receptor for the Growth Factor Pleiotrophin, Journal of Biological Chemistry, vol.276, issue.20, pp.16772-779, 2001.
DOI : 10.1074/jbc.M010660200

Z. Su, G. Liu, S. Gupta, Z. Zhu, M. Rusckowski et al., Integrin for Tumor Imaging, Bioconjugate Chemistry, vol.13, issue.3, pp.561-70, 2002.
DOI : 10.1021/bc0155566

J. Suen, Y. Chuang, B. Tsai, P. Yau, and B. Chiang, Treatment of murine lupus using nucleosomal T cell epitopes identified by bone marrow-derived dendritic cells, Arthritis & Rheumatism, vol.1, issue.10, pp.3250-3259, 2004.
DOI : 10.1002/art.20520

J. Sutcliffe-goulden, M. O-'doherty, P. Marsden, I. Hart, J. Marshall et al., Rapid solid-phase synthesis and biodistribution of 18F-labeled linear peptides

J. Takagi, Structural basis for ligand recognition by RGD (Arg-Gly-Asp)-dependent integrins, Biochemical Society Transactions, vol.32, issue.3, pp.403-409, 2004.
DOI : 10.1042/bst0320403

O. Tricot, Z. Mallat, C. Heymes, J. Belmin, G. Lesèche et al., Relation Between Endothelial Cell Apoptosis and Blood Flow Direction in Human Atherosclerotic Plaques, Circulation, vol.101, issue.21, pp.2450-2453, 2000.
DOI : 10.1161/01.CIR.101.21.2450

H. Trop, A. Davison, A. Jones, M. Davis, D. Szalda et al., Synthesis and physical properties of hexakis(isothiocyanato)technetate(III) and -(IV) complexes. Structure of the [Tc(NCS)6]3- ion, Inorganic Chemistry, vol.19, issue.5, pp.1105-1115, 1980.
DOI : 10.1021/ic50207a001

S. Tsimikas, Noninvasive imaging of oxidized Low-Density Lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies, The American Journal of Cardiology, vol.90, issue.10, pp.22-27, 2002.
DOI : 10.1016/S0002-9149(02)02958-2

G. Tucker, Alpha v integrin inhibitors and cancer therapy, Curr. Opin. Investig. Drugs, vol.4, pp.722-731, 2003.

F. Vacherot, D. Caruelle, D. Chopin, S. Gil-diez, D. Barritault et al., Involvement of heparin affin regulatory peptide in human prostate cancer, The Prostate, vol.31, issue.2, pp.126-136, 1999.
DOI : 10.1002/(SICI)1097-0045(19990201)38:2<126::AID-PROS6>3.0.CO;2-C

C. Van-de-wiele, F. Dumont, R. Dierckx, S. Peers, J. Thornback et al., Biodistribution and dosimetry of 99mTc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies, J. Nucl. Med, vol.42, pp.1722-1729, 2001.

V. Eerd, J. Vegt, E. Wetzels, J. Russel, F. Masereeuw et al., Gelatin-based plasma expander effectively reduces renal uptake of 111 In-octreotide in mice and rats, J. Nucl. Med, vol.47, issue.3, pp.528-561, 2006.

V. Hagen, P. Breeman, W. Bernard, H. Schaar, M. Mooij et al., Evaluation of a radiolabelled cyclic DTPA- RGD Analogue for tumor imaging and radionuclide therapy, Int. J. Cancer, vol.8, pp.186-198, 2000.

E. Vegt, J. Wetzels, F. Russel, R. Masereeuw, O. Boerman et al., Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin, J. Nucl. Med, vol.47, issue.3, pp.432-438, 2006.

I. Virgolini, C. Müller, P. Fitscha, P. Chiba, and H. Sinzinger, Radiolabelling autologous monocytes with 111-indium-oxine for reinjection in patients with atherosclerosis, Prog Clin Biol Res, vol.355, pp.271-80, 1990.

I. Virgolini, P. Angelberger, J. O-'grady, and H. Sinzinger, Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage, European Journal of Nuclear Medicine, vol.18, issue.12, pp.944-951, 1991.
DOI : 10.1007/BF00180412

I. Virgolini, F. Rauscha, G. Lupattelli, P. Angelberger, A. Ventura et al., Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverage, European Journal of Nuclear Medicine, vol.18, issue.12
DOI : 10.1007/BF00180413

P. Jones, Indium-111-Dota-lanreotide: biodistribution,safety and radiation absorbed dose in tumour patients, J. Nucl. Med, vol.39, pp.1928-1936, 1998.

G. Visser, R. Klok, J. Gebbinck, T. Ter-linden, G. Van-dongen et al., Optimal quality 131 I-monoclonal antibodies on high-dose labeling in a large reaction volume and temporarily coating the antibody with IODO-GEN, J. Nucl. Med, vol.42, issue.3, pp.509-528, 2001.

R. Waibei, R. Alberto, J. Willude, R. Finnern, R. Schibli et al., Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex, Nat. Biotechnol, vol.17, pp.897-901, 1999.

R. Weiner and M. Thakur, Radiolabeled Peptides in Oncology, BioDrugs, vol.45, issue.12, pp.145-163, 2005.
DOI : 10.2165/00063030-200519030-00002

R. Weiner and M. Thakur, Radiolabeled peptides in the diagnosis and therapy of oncological diseases, Applied Radiation and Isotopes, vol.57, issue.5, pp.749-763, 2002.
DOI : 10.1016/S0969-8043(02)00192-6

C. Will and R. Lührmann, Spliceosomal UsnRNP biogenesis, structure and function, Current Opinion in Cell Biology, vol.13, issue.3
DOI : 10.1016/S0955-0674(00)00211-8

C. Wittekindt, M. Bottger, H. D. Holtje, M. Schafer-korting, R. Cartier et al., Integrin specificity of the cyclic Arg-Gly-Asp motif and its role in integrin-targeted gene transfer, Biotechnol Appl Biochem, pp.40-281, 2004.

A. Woppmann, C. Will, U. Kornstädt, P. Zuo, J. Manley et al., Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors, Nucleic Acids Research, vol.21, issue.12, pp.2815-2837, 1993.
DOI : 10.1093/nar/21.12.2815

Y. Wu, X. Zhang, Z. Xiong, Z. Cheng, D. Fisher et al., MicroPET imaging of glioma Rv-integrin expression using 64Cu-labeled tetrameric RGD peptide, J. Nucl. Med, vol.46, pp.1707-1718, 2005.

J. Xiong, T. Stehle, B. Diefenbach, R. Zhang, R. Dunker et al., Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3, Science, vol.294, issue.5541, pp.339-384, 2001.
DOI : 10.1126/science.1064535

J. Xiong, T. Stehle, R. Zhang, A. Joachimiak, M. Frech et al., Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 in Complex with an Arg-Gly-Asp Ligand, Science, vol.296, issue.5565, pp.151-155, 2002.
DOI : 10.1126/science.1069040

K. Zaher, M. Rami, A. Makarem, J. Shamseddine, and A. , Understanding the biology of angiogenesis: Review of the most important molecular mechanisms, Blood. Cells. Mol. Dis, vol.39, issue.2, pp.212-232, 2007.

H. Zaidi, Recent developments and future trends in nuclear medicine instrumentation Med, Phys, vol.16, pp.5-17, 2006.

M. Zalutsky, D. Reardon, O. Pozzi, G. Vaidyanathan, and D. Bigner, Targeted alpha-particle radiotherapy with (211)At-labeled monoclonal antibodies, Nucl. Med

B. Zetter, ANGIOGENESIS AND TUMOR METASTASIS, Annual Review of Medicine, vol.49, issue.1, pp.407-424, 1998.
DOI : 10.1146/annurev.med.49.1.407

M. Zhang, D. Gumerov, I. Kaltashov, and A. Mason, Indirect detection of protein-Metal binding: Interaction of serum transferrin with In3+ and Bi3+, Journal of the American Society for Mass Spectrometry, vol.33, issue.186, pp.1658-64, 2004.
DOI : 10.1016/j.jasms.2004.08.009